🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Flora Mulkey

United States Food and Drug Administration

ORCID: 0000-0003-0760-2648

Also affiliated with Center for Drug Evaluation and Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

(2023)10.1158/1078-0432.c.6531153
Top 100%
0DataRank
Top 100%0 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

Papers

Driven by 13 papers — median percentile 0. Top paper: “A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)”.

A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)

American Journal of Hematology(2021)10.1002/ajh.26361
N/A
0.994DataRank · unranked
23 citations

Vera J. Suman, Sascha A. Tuchman, Jacob P. Laubach, Hani Hassoun, Yvonne A. Efebera +7 more

Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0834
N/A
0.700DataRank · unranked
105 citations

Flora Mulkey, Emma Scott, Ashley F. Ward, Donna Przepiorka, Rosane Charlab +9 more

Assessing tolerability of cancer therapeutics: A regulatory perspective from the FDA Oncology Center of Excellence

Cancer(2025)10.1002/cncr.35949
N/A
0.104DataRank · unranked
1 citations

Laura Lee Johnson, Mallorie H. Fiero, Flora Mulkey, Paul Kluetz, Vishal Bhatnagar

Genome-Wide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

medRxiv(2020)10.1101/2020.04.23.20076208
N/A
0DataRank · unranked
2 citations

Chenling Xiong, Carol Ho, Taisei Mushiroda, J Chen, Flora Mulkey +13 more

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

UNC Libraries(2020)10.17615/d8vv-vc17
N/A
0DataRank · unranked
0 citations

William Blum, Flora Mulkey, Richard M. Stone, Shelly Carter, Charles Linker +15 more

Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study

UNC Libraries(2020)10.17615/q2fj-2t55
N/A
0DataRank · unranked
0 citations

Flora Mulkey, Robert Z. Orlowski, Ben L. Sanford, Richard A. Larson, Susan M. Geyer +5 more

Potential Autonomic Risk Factors for Chronic TMD: Descriptive Data and Empirically Identified Domains from the OPPERA Case-Control Study

UNC Libraries(2020)10.17615/f2jn-m070
N/A
0DataRank · unranked
0 citations

Richard Ohrbach, Eric Bair, Luda Diatchenko, Vanessa Miller, Gary D. Slade +6 more

Pain Sensitivity Risk Factors for Chronic TMD: Descriptive Data and Empirically Identified Domains from the OPPERA Case Control Study

UNC Libraries(2020)10.17615/hpe7-st52
N/A
0DataRank · unranked
0 citations

Charlie Knott, Rebecca Rothwell, Gary D. Slade, Ronald Dubner, Flora Mulkey +5 more

FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non–small Cell Lung Cancer, A Collaborative Project Orbis Review

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4338
N/A
0DataRank · unranked
57 citations

Flora Mulkey, Adnan A. Jaigirdar, Lisa Rodríguez, Yibo Wang, Yuan Xu +14 more

Genomewide Meta‐Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent‐Induced Sensory Peripheral Neuropathy

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.1958
N/A
0DataRank · unranked
47 citations

Chenling Xiong, Carol Ho, Taisei Mushiroda, J Chen, Flora Mulkey +13 more

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2389
N/A
0DataRank · unranked
20 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

Data from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

(2023)10.1158/1078-0432.c.6531153
Top 100%
0DataRank
Top 100%0 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3901
N/A
0DataRank · unranked
101 citations

Adnan A. Jaigirdar, Flora Mulkey, Joyce Cheng, Salaheldin S. Hamed, Yangbing Li +16 more